About Synchron
Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic.
Open positions (1)
Company details
Funding
Total raised
$345M
Last stage
Series D
Investors
Founders
Thomas Oxley
Australian-born physician, neuroscientist, and entrepreneur. Founder and CEO of Synchron. His PhD work began in 2012 and he moved to the US in 2015. Also founded SmartStent (acquired by Synchron) and VascuLab.
LinkedInNicholas Opie
Co-founder and Chief Technology Officer at Synchron, focused on the engineering of the Stentrode endovascular brain-computer interface.
Rahul Sharma
Co-founder and Medical Director at Synchron, listed on the company's official About Us page.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.